IVF-Worldwide is proud to announce: a research grant agreement with TEVA for a fertility preservation study in women diagnosed with cancer.
To mark International Women’s Day 2016, IVF Worldwide announce today that it had entered into a research grant agreement with TEVA to investigate the best protocols for women diagnosed with cancer to preserve their fertility before initiating treatment.
Research will compare various fertility preservation protocols in women prior to cancer treatment, by identifying the optimal ovarian stimulation protocol for oocytes/embryos cryopreservation prior to cancer treatment.
The study population includes women with malignant disease who are undergoing controlled ovarian stimulation by r-hFSH (Recombinant human follicle stimulating hormone) for oocytes/embryos cryopreservation prior to chemotherapy or radiotherapy. The primary objective is to compare various controlled ovarian stimulation protocol for oocytes/embryo cryopreservation with respect to the number of oocytes retrieved. The secondary objective is to assess the outcomes of these protocols. The study will take place over the course of three years with data obtained from approximately 100 IVF centers in seven European countries (France, Germany, Italy, Portugal, Spain, The Netherlands and United Kingdom). Data that will be gathered on and by IVF-Worldwide will enable the treating physicians worldwide to understand the role of different stimulation protocols on the treatment outcome.
IVF-Worldwide is looking forward to collaborate in this study with various cancer societies in Europe in educating oncologists of the importance of fertility preservation among young cancer patients. Evidence suggests that fertility preservation options are linked to improving quality of life for cancer survivors. Recent research has found that women who did not undergo pre-treatment fertility preservation experienced regret about their decision as oppose to those who did undergo treatment to preserve their fertility, and that this may consequently affect their psychosocial wellbeing.
This study aims to help physicians choose the best protocol for their patients. It will also raise awareness among oncologists of the opportunities for young women diagnosed with cancer who wish to try and preserve their future fertility.
IVF-WORLDWIDE: ADVANCING EDUCATION AND RESEARCH.
IVF-WORLDWIDE: BECAUSE EDUCATED DOCTORS PROVIDE BETTER PATIENT CARE